Close Menu

More articles about PCR

Finnzymes had $20 million in revenues in 2009 and makes reagents, consumables, kits, and instruments for molecular biology applications.

The University of Pittsburgh will use WaferGen's system for high-throughput gene expression studies.

Zygem will market Rubicon Genomics DNA amplification kits to its Aussie and Kiwi research and molecular diagnostic customers.

Life Tech's sample prep and PCR products for H1N1 testing contributed approximately $15 million in revenue for the fourth quarter and about $45 million for the full year. The company also saw "continued strength in the TaqMan array business, in addition to strong demand for qPCR instrumentation and reagents."

Millipore claims that its test, which incorporates transcription-mediated amplification technology developed by Gen-Probe offshoot Roka Bioscience, provides a few advantages over PCR-based Mycoplasma testing.

Idaho licensed from Applied Biosystems the right to use the TaqMan 5' nuclease process, while ABI licensed from Idaho the right to use SYBR Green in PCR.

The key to the system is helicase-dependent amplification — an isothermal amplification method that is similar to PCR in many ways but does not require a thermal cycler and is therefore more suitable for in-field use.

The inclusion of ABI's PCR-based kit in the FBI's National DNA Index System is expected to drive more widespread use of the kit and solve more crimes, the company said.

Investigators will compare results from the FilmArray PCR test to results from conventional platforms, like viral culture and antibody tests, as well as to results from other molecular diagnostic technologies.

Patent awarded to Shanghai Jiao Tong University.

Genera Biosystems' PapType; OncoVista Innovative Therapies' Adnatest BreastCancer

Product Watch : Jan 28, 2010


Hudson Robotics' SOLO/PCR workcell, Qiagen's QIAsymphony SA, Premier Biosoft International's Beacon Designer 7.7, Idaho Technology's kits for foodborne pathogen detection, Labcyte's Echo Omics Package

The firms have agreed to cross-license technologies related to real-time PCR methods and instruments.

Becton Dickinson, Gen-Probe, and Cepheid updated JP Morgan Healthcare Conference attendees last week on their development timelines for upcoming nucleic acid testing platforms and assays.

The products, which join a line of TaqMan assays for mature microRNAs that Applied Biosystems launched in 2005, are intended to solidify the company's position in the highly competitive RNA research market.

In a new paper, Polyplus-transfection scientists showed that the company's zipped nucleic acids work as hydrolysis probes in quantitative PCR, adding to previous work that demonstrated their use as primers.

The agreement follows another distribution deal that TriLink signed last week.

Patents awarded to Samsung Electronics, Micronics, Sanofi-Pasteur, and Gen-Probe

Myconostica's MycAssay Pneumocystis assay, DiaGenic's ADtect


At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.